A randomized double-blind phase II trial evaluating maintenance PARP inhibitor Olaparib versus placebo in patients with platinum-sensitive advanced non-small cell lung cancer: PIPSeN trial
Por:
Postel-Vinay, S, Planchard, D, Granados, ALO, Gazzah, A, Gonzalez, MAS, Majem, M, Camps, CJ, Abou-Lauvergne, A, Pignon, JP, Cadranel, J, Bennouna, J, Barlesi, F, Campelo, MRG, Viteri, S, Besse, B, Sarto, JC, Sureda, BM, Soria, JC and Rosell, R
Publicada:
1 sep 2017
Resumen:
Filiaciones:
Postel-Vinay, S:
Inst Gustave Roussy, DITEP, Villejuif, France
Planchard, D:
Inst Gustave Roussy, Med Oncol Dept, Villejuif, France
Granados, ALO:
Complejo Hosp Jaen, Oncol Med, Jaen, Spain
Gazzah, A:
Inst Gustave Roussy, DITEP, Villejuif, France
Gonzalez, MAS:
Hosp Basurto, Med Oncol Dept, Bilbao, Spain
Majem, M:
Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain
Camps, CJ:
Hosp Gen Univ Valencia, Med Oncol Dept, Valencia, Spain
Abou-Lauvergne, A:
Inst Gustave Roussy, Rech Clin, Villejuif, France
Pignon, JP:
Inst Gustave Roussy, Dept Biostat, Villejuif, France
Cadranel, J:
Tenon Univ Hosp, AP HP, CancerEst, Med Oncol Dept, Paris, France
Bennouna, J:
CHU Nantes, Oncol, Nantes, France
Barlesi, F:
Aix Marseille Univ, AP HP, Multidisciplinary Oncol & Therapeut Innovat, Marseille, France
Campelo, MRG:
Complejo Hosp Univ A Coruna, Med Oncol, La Coruna, Spain
Viteri, S:
Inst Univ USP Dexeus, Oncol Dept, Barcelona, Spain
Besse, B:
Inst Cancerol Gustave Roussy, Canc Med, Villejuif, France
Sarto, JC:
Hosp Son Llatzer, Med Oncol, Palma De Mallorca, Spain
Sureda, BM:
Hosp Gen Univ Alicante, Med Oncol, Alicante, Spain
Soria, JC:
Inst Gustave Roussy, Med Oncol Dept, Villejuif, France
:
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Med Oncol Dept, Badalona, Spain
|